Screener
Roivant Sciences ROIV Business Segments — Other research and development expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Roivant Sciences in its filing.
Tagged under the XBRL concept us-gaap:OtherResearchAndDevelopmentExpense.
The source filing: Roivant Sciences’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001635088-26-000090
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 |
|---|---|---|
| Other development and discovery programs | 11,118 | 10,236 |
| Research and development share-based compensation | 8,721 | 11,099 |
| Research and development personnel-related expenses | 46,354 | 42,530 |
| Other research and development expenses | 7,859 | 9,637 |
| General and administrative share-based compensation | 74,621 | 71,079 |
| General and administrative personnel-related expenses | 56,200 | 30,110 |
| Other general and administrative expenses | 34,706 | 32,830 |
| Gain on litigation settlement | (392) | — |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Roivant Sciences's business segments — other research and development expenses?
- Roivant Sciences (ROIV) reported business segments — other research and development expenses of $7.86M in Q2 2026.
- What does business segments — other research and development expenses mean?
- This metric captures non-personnel research and development costs, such as clinical trial expenses, laboratory supplies, and third-party research service fees, attributable to a specific business segment. It reflects the direct financial commitment to advancing the pipeline and innovation within that particular area of the business. Tracking these expenses is critical for evaluating the capital efficiency of the segment's drug development programs.
Ask your AI about Roivant Sciences's business segments — other research and development expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude